SlideShare a Scribd company logo
1 of 17
Presented By :
Raisa Imam
TOPIC : MANUFACTURING TECHNIQUE
OF PARENTERAL PRODUCTS
PRESENTATION ON
Manufacturing Technique of Parenteral Products
CONTENT
 Introduction
 Advantages & Disadvantages
 Types
 Formulation
 LVP
 Manufactuing of LVP
 SVP
 Manufacturing of SVP
 LVP VS SVP
 Conclusion
OBJECTIVE
To get introduced with the Manufacturing technique
of Parenteral Preparations.
To get discussed about the process of Parenteral
Preparation Manufacturing
INTRODUCTION
Parenteral
Products
Greek word”
Para” outside
& “Enterone”
Intestine
Administered
directly in the
veins ,
muscles or
under the skin
Term parenteral
used for any
drugfluid whose
delivery doesn’t
utilize the
alimentary canal
Sterile
solutions or
suspension of
drugs in
aqueous or
oily vehicle
Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage
Forms:Parenterals,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:346-348
Advantages Disadvantages
1.Quick onset 2.Wrong dose or overdose
can be fatal
2.Vomittng and unconscious
patients can take
2.Pain at side
3.Prolonged action modified
formulation (Depot)
3.Trained person required
4.Nutritive fluids can be given 4.Expensive
5.Drugs with poor absorbtion or
instability from GT
5.Necessity of aseptic
conditions in
production,compounding and
administration.
Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage
Forms:Parentrals,Volumes 1.2nd Edition.New Delhi,India:Taylor &
Francis,1989p:346-348
Classification of Parenteral Preparations :
Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage
Forms:Tablets,Volumes 1.2nd Edition.New Delhi,India:Taylor &
Francis,1989p:346-348
• Single dose units
• Infusion solution
• Multiple dose units
According to
Packaging dose
units
• Small volume
parenteral (SVP)
• Large volume
parenteral (LVP)
According to
volume
FORMULATION
Active Ingredients
Vehicle
WFI
SWFI
Water
miscible
vehicle
BWFI
Non-
aqous
vehicle
Additiv
e
Antimi
cribial
Antioxi
dent
Buffer
Bufferi
ng
Agents
Chelati
g
Agents
Surfact
ant
Solibuli
zing
Agent
Tonicity
Adjusting
Agent
Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical
Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott
Williams & Wilkins, 2011.Page No:470-473
LARGE-VOLUME PARENTERALS
Lvp are Parenterals designed to provide
Most common LVP’s are 0.9% sodium chloride, dextrose 5% in water,
dextrose 5% in normal saline & LR solution.Volume 101-1000ml
(250ml,500ml & 1000ml mostly)
Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical
Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams &
Wilkins, 2011.Page No:470-473
Fluid
(Water)
Calories
(Dextrose
solution)
Electrolytes
(Saline
Solutin)
Combination
of these
MANUFACTURING OF LVP(SALINE)
BFS
(Blow Fill
and Sealed
Technology )
1.Parison
Extrusion
2..Contai
ner
Molding
3.Contain
er Filling
4.Contain
er
Sealing
BFS
Preservative
free single
dose
Asepctically
manufactured
sterile
product
NO human
intervention,a
utomated.
Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage
Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins,
2011.Page No:470-473
SMALL VOLUME PARENTERALS
Volume less than 100ml
Usually range 1-30ml in
volume
Mostly given as multiple
dose
Types
Ampul
es
Dry
powder
Prefille
d
Syring
e
Vials
Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical
Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams &
Wilkins, 2011.Page No:470-473
MANUFACTURING OF SVP (AMPULES)
Ingrediants,Vehicles
Compounding of the
product & Filtration of
the solute
Processing
equipments &
cleaning
Container
Component
Cleaning
Sterilization
Filling Sealing
Packing
Product storage
Ref: Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage
Forms:Tablets,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:344-346
MANUFACTURING OF SVP
LVP VS SVP
Parameters SVP LVP
Volume 100ml or less 101-1000ml
Routes IV, IM & SC IV-LVP & non IV-LVP
Dosage Unit Single or multiple Single
Preservative Used Not used
Buffers Used Not used
Formulation Solution,emulsion,sus
pension
Solution & o/w nutrient
emulsion
Isotonicity Not essential Must
Pyrogenicity Not essential Must
Use Therapeutic &
Diagonistic
Nutrition,detoxification
and during surgery
Ref:Jisna Sibastian.Prenteral preparations education blog[Internet]Published
in: Slideshare on Jul 1,2016 available at
https://www.slideshare.net/JisnaSebastian/parenteral-preparationsRef
CONCLUSION
Despite of aseptic
technique in
production,compou
nding and handling
of product this is
the most effective
route for the
delivery of active
pharmaceutical
substances
specially when
drugs cannot be
taken orally
Alternative route
for the drugs that
are highly
hydrophobic as
these drugs
cannot pass
through cell
memrane
08 pn

More Related Content

Similar to 08 pn

Small-Volume Parenteral Preparations
Small-Volume Parenteral Preparations Small-Volume Parenteral Preparations
Small-Volume Parenteral Preparations
Kdurant36
 
Large-Volume Parenteral Preparations
Large-Volume Parenteral Preparations Large-Volume Parenteral Preparations
Large-Volume Parenteral Preparations
Kdurant36
 
Clinical trials and drug discovery & development 01-03-2011
Clinical trials and drug discovery & development 01-03-2011Clinical trials and drug discovery & development 01-03-2011
Clinical trials and drug discovery & development 01-03-2011
nadirqureshi996
 
NTR 340 Nutrition Research Questionnaire- USE ME(1)
NTR 340 Nutrition Research Questionnaire- USE ME(1)NTR 340 Nutrition Research Questionnaire- USE ME(1)
NTR 340 Nutrition Research Questionnaire- USE ME(1)
Laurie Hill
 

Similar to 08 pn (20)

Large volume parenterals
Large volume parenteralsLarge volume parenterals
Large volume parenterals
 
Small-Volume Parenteral Preparations
Small-Volume Parenteral Preparations Small-Volume Parenteral Preparations
Small-Volume Parenteral Preparations
 
Large-Volume Parenteral Preparations
Large-Volume Parenteral Preparations Large-Volume Parenteral Preparations
Large-Volume Parenteral Preparations
 
NDDS.pptx
NDDS.pptxNDDS.pptx
NDDS.pptx
 
Ppt 2011
Ppt 2011Ppt 2011
Ppt 2011
 
Nanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery systemNanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery system
 
Clinical trials and drug discovery & development 01-03-2011
Clinical trials and drug discovery & development 01-03-2011Clinical trials and drug discovery & development 01-03-2011
Clinical trials and drug discovery & development 01-03-2011
 
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEMROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
 
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEMROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
 
Herbal Drug Delivery System
Herbal Drug Delivery SystemHerbal Drug Delivery System
Herbal Drug Delivery System
 
Op RDS
Op RDSOp RDS
Op RDS
 
penicillin
penicillin penicillin
penicillin
 
PARENTRAL DOSAGE FORM OR STERILE DOSAGE FORM
PARENTRAL DOSAGE FORM OR  STERILE DOSAGE FORMPARENTRAL DOSAGE FORM OR  STERILE DOSAGE FORM
PARENTRAL DOSAGE FORM OR STERILE DOSAGE FORM
 
NTR 340 Nutrition Research Questionnaire- USE ME(1)
NTR 340 Nutrition Research Questionnaire- USE ME(1)NTR 340 Nutrition Research Questionnaire- USE ME(1)
NTR 340 Nutrition Research Questionnaire- USE ME(1)
 
Xenobiotic 24 12-15
Xenobiotic 24 12-15Xenobiotic 24 12-15
Xenobiotic 24 12-15
 
Advances in pharmacy
Advances in pharmacyAdvances in pharmacy
Advances in pharmacy
 
Enzymes
EnzymesEnzymes
Enzymes
 
Iv admixtures PPT
Iv admixtures PPTIv admixtures PPT
Iv admixtures PPT
 
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdfCelerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
 
Industrial production of pencillin
Industrial production of pencillinIndustrial production of pencillin
Industrial production of pencillin
 

Recently uploaded

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 

Recently uploaded (20)

Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
HyperIgE syndrome: primary immune deficiency.pdf
HyperIgE syndrome: primary immune deficiency.pdfHyperIgE syndrome: primary immune deficiency.pdf
HyperIgE syndrome: primary immune deficiency.pdf
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 

08 pn

  • 1. Presented By : Raisa Imam TOPIC : MANUFACTURING TECHNIQUE OF PARENTERAL PRODUCTS
  • 3. CONTENT  Introduction  Advantages & Disadvantages  Types  Formulation  LVP  Manufactuing of LVP  SVP  Manufacturing of SVP  LVP VS SVP  Conclusion
  • 4. OBJECTIVE To get introduced with the Manufacturing technique of Parenteral Preparations. To get discussed about the process of Parenteral Preparation Manufacturing
  • 5. INTRODUCTION Parenteral Products Greek word” Para” outside & “Enterone” Intestine Administered directly in the veins , muscles or under the skin Term parenteral used for any drugfluid whose delivery doesn’t utilize the alimentary canal Sterile solutions or suspension of drugs in aqueous or oily vehicle Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage Forms:Parenterals,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:346-348
  • 6. Advantages Disadvantages 1.Quick onset 2.Wrong dose or overdose can be fatal 2.Vomittng and unconscious patients can take 2.Pain at side 3.Prolonged action modified formulation (Depot) 3.Trained person required 4.Nutritive fluids can be given 4.Expensive 5.Drugs with poor absorbtion or instability from GT 5.Necessity of aseptic conditions in production,compounding and administration. Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage Forms:Parentrals,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:346-348
  • 7. Classification of Parenteral Preparations : Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage Forms:Tablets,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:346-348 • Single dose units • Infusion solution • Multiple dose units According to Packaging dose units • Small volume parenteral (SVP) • Large volume parenteral (LVP) According to volume
  • 8. FORMULATION Active Ingredients Vehicle WFI SWFI Water miscible vehicle BWFI Non- aqous vehicle Additiv e Antimi cribial Antioxi dent Buffer Bufferi ng Agents Chelati g Agents Surfact ant Solibuli zing Agent Tonicity Adjusting Agent Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins, 2011.Page No:470-473
  • 9. LARGE-VOLUME PARENTERALS Lvp are Parenterals designed to provide Most common LVP’s are 0.9% sodium chloride, dextrose 5% in water, dextrose 5% in normal saline & LR solution.Volume 101-1000ml (250ml,500ml & 1000ml mostly) Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins, 2011.Page No:470-473 Fluid (Water) Calories (Dextrose solution) Electrolytes (Saline Solutin) Combination of these
  • 10. MANUFACTURING OF LVP(SALINE) BFS (Blow Fill and Sealed Technology ) 1.Parison Extrusion 2..Contai ner Molding 3.Contain er Filling 4.Contain er Sealing BFS Preservative free single dose Asepctically manufactured sterile product NO human intervention,a utomated. Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins, 2011.Page No:470-473
  • 11.
  • 12. SMALL VOLUME PARENTERALS Volume less than 100ml Usually range 1-30ml in volume Mostly given as multiple dose Types Ampul es Dry powder Prefille d Syring e Vials Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins, 2011.Page No:470-473
  • 13. MANUFACTURING OF SVP (AMPULES) Ingrediants,Vehicles Compounding of the product & Filtration of the solute Processing equipments & cleaning Container Component Cleaning Sterilization Filling Sealing Packing Product storage Ref: Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage Forms:Tablets,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:344-346
  • 15. LVP VS SVP Parameters SVP LVP Volume 100ml or less 101-1000ml Routes IV, IM & SC IV-LVP & non IV-LVP Dosage Unit Single or multiple Single Preservative Used Not used Buffers Used Not used Formulation Solution,emulsion,sus pension Solution & o/w nutrient emulsion Isotonicity Not essential Must Pyrogenicity Not essential Must Use Therapeutic & Diagonistic Nutrition,detoxification and during surgery Ref:Jisna Sibastian.Prenteral preparations education blog[Internet]Published in: Slideshare on Jul 1,2016 available at https://www.slideshare.net/JisnaSebastian/parenteral-preparationsRef
  • 16. CONCLUSION Despite of aseptic technique in production,compou nding and handling of product this is the most effective route for the delivery of active pharmaceutical substances specially when drugs cannot be taken orally Alternative route for the drugs that are highly hydrophobic as these drugs cannot pass through cell memrane